Floyd R A, Kuo C Y, Yoo T J, Song A, Postlethwaite A E, Mainardi C
J Lab Clin Med. 1984 Feb;103(2):215-22.
The ability of protease inhibitors to modulate NK and ADCC cell activities was studied. NK and ADCC cell activities were suppressed by 1,10 phenanthroline (PHE), N-alpha-p-tosyl-L-lysine chloromethyl ketone (TLCK), L-1-tosylamide-2-phenylethylchoromethyl ketone (TPCK), N-benzoyl-DL-tyrosine ethyl ester (BTEE), and phenylethylchoromethyl fluoride (PMSF). The effect of these protease inhibitors on ADCC was not mediated through the early phase of cytotoxicity involving Fc-receptor binding, since they failed to alter EoxA rosetting of effector cells. The results suggest that an activated esterase system might play a role in the later phase of the cytotoxic mechanism by ADCC cells and perhaps NK cells.
研究了蛋白酶抑制剂调节自然杀伤(NK)细胞和抗体依赖的细胞介导的细胞毒性(ADCC)细胞活性的能力。1,10-菲咯啉(PHE)、N-α-对甲苯磺酰-L-赖氨酸氯甲基酮(TLCK)、L-1-甲苯磺酰胺-2-苯乙基氯甲基酮(TPCK)、N-苯甲酰-DL-酪氨酸乙酯(BTEE)和苯乙基氯甲基氟化物(PMSF)可抑制NK细胞和ADCC细胞的活性。这些蛋白酶抑制剂对ADCC的作用并非通过涉及Fc受体结合的细胞毒性早期阶段介导,因为它们未能改变效应细胞的EoxA玫瑰花结形成。结果表明,活化的酯酶系统可能在ADCC细胞以及或许NK细胞的细胞毒性机制后期发挥作用。